Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ehp-101
2. 1818428-24-8
3. Vce-004.8
4. Vce-004
5. (1'r,6'r)-3-(benzylamine)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-(1,1'-bi(cyclohexane))-2',3,6-triene-2,5-dione
6. 2,5-cyclohexadiene-1,4-dione, 2-hydroxy-3-((1r,6r)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-6-pentyl-5-((phenylmethyl)amino)-
7. (1'r,6'r)-3-(benzylamino)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-(1,1'-bi(cyclohexane))-2',3,6-triene-2,5-dione
8. (1'r,6'r)-3-(benzylamino)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-[1,1'-bi(cyclohexane)]-2',3,6-triene-2,5-dione
9. Unii-ktjciknf3f
10. Schembl17197618
11. Bdbm482299
12. Us10919843, Compound Viii
13. Ex-a3105
14. Zb1584
15. Vce-?004.8
16. Ac-36333
17. Ehp-101 (vce- 004.8)
18. Hy-128872
19. Cs-0101637
20. 5-(benzylamino)-4-hydroxy-3-[(1r,6r)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-6-pentylcyclohexa-3,5-diene-1,2-dione
| Molecular Weight | 433.6 g/mol |
|---|---|
| Molecular Formula | C28H35NO3 |
| XLogP3 | 6.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 9 |
| Exact Mass | 433.26169398 g/mol |
| Monoisotopic Mass | 433.26169398 g/mol |
| Topological Polar Surface Area | 66.4 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 839 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
44
PharmaCompass offers a list of EHP-101 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right EHP-101 manufacturer or EHP-101 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred EHP-101 manufacturer or EHP-101 supplier.
PharmaCompass also assists you with knowing the EHP-101 API Price utilized in the formulation of products. EHP-101 API Price is not always fixed or binding as the EHP-101 Price is obtained through a variety of data sources. The EHP-101 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A EHP-101 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of EHP-101, including repackagers and relabelers. The FDA regulates EHP-101 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. EHP-101 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A EHP-101 supplier is an individual or a company that provides EHP-101 active pharmaceutical ingredient (API) or EHP-101 finished formulations upon request. The EHP-101 suppliers may include EHP-101 API manufacturers, exporters, distributors and traders.
EHP-101 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of EHP-101 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right EHP-101 GMP manufacturer or EHP-101 GMP API supplier for your needs.
A EHP-101 CoA (Certificate of Analysis) is a formal document that attests to EHP-101's compliance with EHP-101 specifications and serves as a tool for batch-level quality control.
EHP-101 CoA mostly includes findings from lab analyses of a specific batch. For each EHP-101 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
EHP-101 may be tested according to a variety of international standards, such as European Pharmacopoeia (EHP-101 EP), EHP-101 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (EHP-101 USP).
